Riding the pepTIDE — The Daily Wire on Therapeutic Peptides

An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.

Topic Sections

  • Top Shots — The most significant peptide and longevity stories ranked by overall editorial score
  • Research Signals — High-credibility scientific findings from journals, preprints, and clinical sources
  • Healing & Recovery — Tissue repair, injury recovery, and gut healing peptides including BPC-157 and TB-500
  • Growth Hormone Wire — Growth hormone secretagogues, peptide stacks, and GH axis research including Ipamorelin, CJC-1295, and MK-677
  • Metabolic & GLP-1 — Metabolic health, insulin sensitivity, and GLP-1 receptor agonist research including semaglutide and tirzepatide
  • Cognitive / Nootropic — Peptides targeting brain function, memory, neuroprotection, and cognitive enhancement
  • Skin & Cosmetic — Skin repair, anti-aging, collagen synthesis, and cosmetic peptide research including GHK-Cu and matrixyl
  • Reddit Finds — Community-sourced discussions, self-experimentation reports, and protocol threads from peptide communities
  • Contrarian Takes — Alternative viewpoints, dissenting research, and perspectives that challenge mainstream peptide narratives
  • Skeptic's Corner — Hype debunking, low-evidence alerts, and critical analysis of overstated peptide claims

Browse by Filter

  • Newest — Latest peptide and longevity stories
  • Most Credible — Highest credibility-scored stories
  • Most Edgy — High-novelty, unconventional findings
  • Most Discussed — Trending community discussions
  • Most Actionable — Direct applicability to daily health protocols
  • Lowest Risk — Stories with strong evidence, low hype
  • Research Only — Peer-reviewed and preprint studies
  • Reddit Only — Community discussion and anecdote
  • GLP-1 / Metabolic — Semaglutide, tirzepatide, and metabolic peptides
  • Healing / Recovery — BPC-157, TB-500, and repair protocols

More

  • About Riding the pepTIDE
  • Health Disclaimer
  • Submit a Source
  • Contact

Stalled on Mounjaro for Months — How to Restart Weight Loss?

Someone on an online forum said they started taking Mounjaro (a diabetes and weight-loss drug) in mid-October and dropped from 248 to 224 pounds, but then stalled: they’ve been stuck within two pounds of that weight since mid-February despite being on a 10 mg dose. They’re asking for tips to restart weight loss and noting their target of losing about 15% of body weight to reach roughly 206 pounds. Mounjaro is the brand name for tirzepatide. It’s a man-made version of gut hormones that normally help control blood sugar and appetite. In plain terms, it tricks your body into feeling less hungry and helps slow digestion a bit, so people often eat less and lose weight. It’s given by injection and is used for type 2 diabetes; higher doses are also being used specifically for weight loss. It’s not a magic pill — it changes the signals that help regulate hunger and blood sugar. The person’s report is an anecdote — one person’s experience, not a formal study. Real clinical trials of tirzepatide have shown large average weight losses in groups of people, but individual responses vary a lot. Plateaus are common: many people lose weight more quickly at first and then slow down. A stall like a few months where weight stays within a small range is something doctors and researchers see, especially once you’re leaner or if eating, activity, or medication dose changes. The post doesn’t say if other factors changed — like calorie intake, exercise, sleep, stress, other meds, or whether their dose was adjusted — so we can’t know why they stalled. Why this matters to regular people: lots of people are using drugs like Mounjaro for weight control and want to know what’s typical. Hearing about a plateau is useful because it sets expectations: initial rapid loss often gives way to slower progress, and patience plus small tweaks often help. For someone aiming for a 15% reduction, a plateau can feel discouraging, but it doesn’t mean failure. It may mean adjustments — under a doctor’s guidance — to diet, activity, medication dose, or addressing other health issues that affect weight. Important cautions: this post is not medical advice. Mounjaro and similar drugs have side effects (nausea, vomiting, diarrhea, and more rare but serious risks) and should be used under medical supervision. Changing doses, stopping the drug, or adding other medications should only happen with a clinician. Also, weight plateaus can be caused by many things — thyroid problems, injuries, stress, or inaccurate tracking — so a check-in with a healthcare provider helps. Finally, individual stories don’t replace clinical evidence; if someone is unhappy with their progress, the safest route is to talk to their prescribing clinician about possible causes and options. Bottom line: a months-long weight plateau on Mounjaro is common and solvable, but fixes should be personalized and done with medical guidance.

Source: r/Mounjaro

Read full story

Back to Riding the pepTIDE